Cerebrovascular morphology plays a critical role in brain health, influencing cerebral blood flow (CBF) and contributing to the pathogenesis of various neurological diseases. This review examines the anatomical structure of the cerebrovascular network and its variations in healthy and diseased populations and highlights age-related changes and their implications in various neurological conditions. Normal variations, including the completeness and anatomical anomalies of the Circle of Willis and collateral circulation, are discussed in relation to their impact on CBF and susceptibility to ischemic events. Age-related changes in the cerebrovascular system, such as alterations in vessel geometry and density, are explored for their contributions to age-related neurological disorders, including Alzheimer's disease and vascular dementia. Advances in medical imaging and computational methods have enabled automatic quantitative assessment of cerebrovascular structures, facilitating the identification of pathological changes in both acute and chronic cerebrovascular disorders. Emerging technologies, including machine learning and computational fluid dynamics, offer new tools for predicting disease risk and patient outcomes based on vascular morphology. This review underscores the importance of understanding cerebrovascular remodeling for early diagnosis and the development of novel therapeutic approaches in brain diseases.

This work aimed to develop deep learning (DL) models for CT-free attenuation and Monte Carlo-based scatter correction (AC, SC) in quantitative ⁹⁰Y SPECT imaging for improved dose calculation. Data of 190 patients who underwent ⁹⁰Y selective internal radiation therapy (SIRT) with glass microspheres was studied. Voxel-level dosimetry was performed on uncorrected and corrected SPECT images using the local energy deposition method. Three deep learning models were trained individually for AC, SC, and joint ASC using a modified 3D shifted-window UNet Transformer (Swin UNETR) architecture. Corrected and unorrected dose maps served as reference and as inputs, respectively. The data was split into train set (~ 80%) and unseen test set (~ 20%). Training was conducted in a five-fold cross-validation scheme. The trained models were tested on the unseen test set. The model's performance was thoroughly evaluated by comparing organ- and voxel-level dosimetry results between the reference and DL-generated dose maps on the unseen test dataset. The voxel and organ-level evaluations also included Gamma analysis with three different distances to agreement (DTA (mm)) and dose difference (DD (%)) criteria to explore suitable criteria in SIRT dosimetry using SPECT. The average ± SD of the voxel-level quantitative metrics for AC task, are mean error (ME (Gy)): -0.026 ± 0.06, structural similarity index (SSIM (%)): 99.5 ± 0.25, and peak signal to noise ratio (PSNR (dB)): 47.28 ± 3.31. These values for SC task are - 0.014 ± 0.05, 99.88 ± 0.099, 55.9 ± 4, respectively. For ASC task, these values are as follows: -0.04 ± 0.06, 99.57 ± 0.33, 47.97 ± 3.6, respectively. The results of voxel level gamma evaluations with three different criteria, namely "DTA: 4.79, DD: 1%", "DTA:10 mm, DD: 5%", and "DTA: 15 mm, DD:10%" were around 98%. The mean absolute error (MAE (Gy)) for tumor and whole normal liver across tasks are as follows: 7.22 ± 5.9 and 1.09 ± 0.86 for AC, 8 ± 9.3 and 0.9 ± 0.8 for SC, and 11.8 ± 12.02 and 1.3 ± 0.98 for ASC, respectively. We developed multiple models for three different clinically scenarios, namely AC, SC, and ASC using the patient-specific Monte Carlo scatter corrected and CT-based attenuation corrected images. These task-specific models could be beneficial to perform the essential corrections where the CT images are either not available or not reliable due to misalignment, after training with a larger dataset.

BackgroundThe precise pneumoconiosis staging suffers from progressive pair label noise (PPLN) in chest X-ray datasets, because adjacent stages are confused due to unidentifialble and diffuse opacities in the lung fields. As deep neural networks are employed to aid the disease staging, the performance is degraded under such label noise.ObjectiveThis study improves the effectiveness of pneumoconiosis staging by mitigating the impact of PPLN through network architecture refinement and sample selection mechanism adjustment.MethodsWe propose a novel multi-branch architecture that incorporates the dual-threshold sample selection. Several auxiliary branches are integrated in a two-phase module to learn and predict the <i>progressive feature tendency</i>. A novel difference-based metric is introduced to iteratively obtained the instance-specific thresholds as a complementary criterion of dynamic sample selection. All the samples are finally partitioned into <i>clean</i> and <i>hard</i> sets according to dual-threshold criteria and treated differently by loss functions with penalty terms.ResultsCompared with the state-of-the-art, the proposed method obtains the best metrics (accuracy: 90.92%, precision: 84.25%, sensitivity: 81.11%, F1-score: 82.06%, and AUC: 94.64%) under real-world PPLN, and is less sensitive to the rise of synthetic PPLN rate. An ablation study validates the respective contributions of critical modules and demonstrates how variations of essential hyperparameters affect model performance.ConclusionsThe proposed method achieves substantial effectiveness and robustness against PPLN in pneumoconiosis dataset, and can further assist physicians in diagnosing the disease with a higher accuracy and confidence.

The classification of renal cell carcinoma (RCC) histological subtypes plays a crucial role in clinical diagnosis. However, traditional image normalization methods often struggle with discrepancies arising from differences in imaging parameters, scanning devices, and multi-center data, which can impact model robustness and generalizability. This study included 1628 patients with pathologically confirmed RCC who underwent nephrectomy across eight cohorts. These were divided into a training set, a validation set, external test dataset 1, and external test dataset 2. We proposed an "Aortic Enhancement Normalization" (AEN) method based on the lesion-to-aorta enhancement ratio and developed an automated lesion segmentation model along with a multi-scale CT feature extractor. Several machine learning algorithms, including Random Forest, LightGBM, CatBoost, and XGBoost, were used to build classification models and compare the performance of the AEN and traditional approaches for evaluating histological subtypes (clear cell renal cell carcinoma [ccRCC] vs. non-ccRCC). Additionally, we employed SHAP analysis to further enhance the transparency and interpretability of the model's decisions. The experimental results demonstrated that the AEN method outperformed the traditional normalization method across all four algorithms. Specifically, in the XGBoost model, the AEN method significantly improved performance in both internal and external validation sets, achieving AUROC values of 0.89, 0.81, and 0.80, highlighting its superior performance and strong generalizability. SHAP analysis revealed that multi-scale CT features played a critical role in the model's decision-making process. The proposed AEN method effectively reduces the impact of imaging parameter differences, significantly improving the robustness and generalizability of histological subtype (ccRCC vs. non-ccRCC) models. This approach provides new insights for multi-center data analysis and demonstrates promising clinical applicability.

Introduction Contrast enema (CE) is widely used in the evaluation of suspected Hirschsprung disease (HD). Deep learning is a promising tool to standardize image assessment and support clinical decision-making. This study assesses the diagnostic performance of a deep neural network (DNN), with and without clinical data, and compares its interpretation with that of pediatric surgeons and radiologists. Materials and Methods In this retrospective study, 1471 contrast enema images from patients <15 years were analysed, with 218 images used for testing. A deep neural network, pediatric radiologists, and surgeons independently reviewed the testing set, with and without clinical data. Diagnostic performance was assessed using ROC and PR curves, and interobserver agreement was evaluated using Fleiss' kappa. Results The deep neural network achieved high diagnostic accuracy (AUC-ROC = 0.87) in contrast enema interpretation, with improved performance when combining anteroposterior and lateral images (AUC-ROC = 0.92). Clinical data integration further enhanced model sensitivity and negative predictive value. The super-surgeon (majority voting of colorectal surgeons) outperformed most individual clinicians (sensitivity 81.8%, specificity 79.1%), while the super-radiologist (majority voting of radiologist) showed moderate accuracy. Interobserver analysis revealed strong agreement between the model and surgeons (Cohen's kappa = 0.73), and overall consistency among experts and the model (Fleiss' kappa = 0.62). Conclusions AI-assisted CE interpretation achieved higher specificity and comparable sensitivity to those of the clinicians. Its consistent performance and substantial agreement with experts support its potential role in improving CE assessment in HD.

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with early detection playing a crucial role in improving survival rates. Artificial intelligence (AI), particularly in medical image analysis, has emerged as a potential tool for HCC diagnosis and surveillance. Recent advancements in deep learning-driven medical imaging have demonstrated significant potential in enhancing early HCC detection, particularly in ultrasound (US)-based surveillance. This review provides a comprehensive analysis of the current landscape, challenges, and future directions of AI in HCC surveillance, with a specific focus on the application in US imaging. Additionally, it explores AI's transformative potential in clinical practice and its implications for improving patient outcomes. We examine various AI models developed for HCC diagnosis, highlighting their strengths and limitations, with a particular emphasis on deep learning approaches. Among these, convolutional neural networks have shown notable success in detecting and characterising different focal liver lesions on B-mode US often outperforming conventional radiological assessments. Despite these advancements, several challenges hinder AI integration into clinical practice, including data heterogeneity, a lack of standardisation, concerns regarding model interpretability, regulatory constraints, and barriers to real-world clinical adoption. Addressing these issues necessitates the development of large, diverse, and high-quality data sets to enhance the robustness and generalisability of AI models. Emerging trends in AI for HCC surveillance, such as multimodal integration, explainable AI, and real-time diagnostics, offer promising advancements. These innovations have the potential to significantly improve the accuracy, efficiency, and clinical applicability of AI-driven HCC surveillance, ultimately contributing to enhanced patient outcomes.

Accurate preoperative prediction of spread through air spaces (STAS) in primary lung adenocarcinoma (LUAD) is critical for optimizing surgical strategies and improving patient outcomes. To develop a machine learning (ML) based model to predict STAS using preoperative CT imaging features and clinicopathological data, while enhancing interpretability through shapley additive explanations (SHAP) analysis. This multicenter retrospective study included 1237 patients with pathologically confirmed primary LUAD from three hospitals. Patients from Center 1 (n=932) were divided into a training set (n=652) and an internal test set (n=280). Patients from Centers 2 (n=165) and 3 (n=140) formed external validation sets. CT imaging features and clinical variables were selected using Boruta and least absolute shrinkage and selection operator regression. Seven ML models were developed and evaluated using five-fold cross-validation. Performance was assessed using F1 score, recall, precision, specificity, sensitivity, and area under the receiver operating characteristic curve (AUC). The Extreme Gradient Boosting (XGB) model achieved AUCs of 0.973 (training set), 0.862 (internal test set), and 0.842/0.810 (external validation sets). SHAP analysis identified nodule type, carcinoembryonic antigen, maximum nodule diameter, and lobulated sign as key features for predicting STAS. Logistic regression analysis confirmed these as independent risk factors. The XGB model demonstrated high predictive accuracy and interpretability for STAS. By integrating widely available clinical and imaging features, this model offers a practical and effective tool for preoperative risk stratification, supporting personalized surgical planning in primary LUAD management.

This study aimed to develop and validate convolutional neural network (CNN) models for distinguishing follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA). Additionally, this current study compared the performance of CNN models with the American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TIRADS) and Chinese Thyroid Imaging Reporting and Data System (C-TIRADS) ultrasound-based malignancy risk stratification systems. A total of 327 eligible patients with FTC and FTA who underwent preoperative thyroid ultrasound examination were retrospectively enrolled between August 2017, and August 2024. Patients were randomly assigned to a training cohort (n = 263) and a test cohort (n = 64) in an 8:2 ratio using stratified sampling. Five CNN models, including VGG16, ResNet101, MobileNetV2, ResNet152, and ResNet50, pre-trained with ImageNet, were developed and tested to distinguish FTC from FTA. The CNN models exhibited good performance, yielding areas under the receiver operating characteristic curve (AUC) ranging from 0.64 to 0.77. The ResNet152 model demonstrated the highest AUC (0.77; 95% CI, 0.67-0.87) for distinguishing between FTC and FTA. Decision curve and calibration curve analyses demonstrated the models' favorable clinical value and calibration. Furthermore, when comparing the performance of the developed models with that of the C-TIRADS and ACR-TIRADS systems, the models developed in this study demonstrated superior performance. This can potentially guide appropriate management of FTC in patients with follicular neoplasms.

Anterior Cruciate Ligament (ACL) tears are common in sports and can provide noteworthy health issues. Therefore, accurately diagnosing of tears is important for the early and proper treatment. However, traditional diagnostic methods, such as clinical assessments and MRI, have limitations in terms of accuracy and efficiency. This study introduces a new diagnostic approach by combining of the deep learning architecture Res2Net with an improved version of the Lévy flight distribution (ILFD) to improve the detection of ACL tears in knee MRI images. The Res2Net model is known for its ability to extract important features and classify them effectively. By optimizing the model using the ILFD algorithm, the diagnostic efficiency is greatly improved. For validation of the proposed model's efficiency, it has been applied into two standard datasets including Stanford University Medical Center and Clinical Hospital Centre Rijeka. Comparative analysis with existing diagnostic methods, including 14 layers ResNet-14, Compact Parallel Deep Convolutional Neural Network (CPDCNN), Convolutional Neural Network (CNN), Generative Adversarial Network (GAN), and combined CNN and Modified Golden Search Algorithm (CNN/MGSA) shows that the suggested Res2Net/ILFD model performs better in various metrics, including precision, recall, accuracy, f1-score, and specificity, and Matthews correlation coefficient.

The composition of the tumour microenvironment is very complex, and measuring the extent of immune cell infiltration can provide an important guide to clinically significant treatments for cancer, such as immune checkpoint inhibition therapy and targeted therapy. We used multiple machine learning (ML) models to predict differences in immune infiltration in clear cell renal cell carcinoma (ccRCC), with computed tomography (CT) imaging pictures serving as a model for machine learning. We also statistically analysed and compared the results of multiple typing models and explored an excellent non-invasive and convenient method for treatment of ccRCC patients and explored a better, non-invasive and convenient prediction method for ccRCC patients. The study included 539 ccRCC samples with clinicopathological information and associated genetic information from The Cancer Genome Atlas (TCGA) database. The Single Sample Gene Set Enrichment Analysis (ssGSEA) algorithm was used to obtain the immune cell infiltration results as well as the cluster analysis results. ssGSEA-based analysis was used to obtain the immune cell infiltration levels, and the Boruta algorithm was further used to downscale the obtained positive/negative gene sets to obtain the immune infiltration level groupings. Multifactor Cox regression analysis was used to calculate the immunotherapy response of subgroups according to Tumor Immune Dysfunction and Exclusion (TIDE) algorithm and subgraph algorithm to detect the difference in survival time and immunotherapy response of ccRCC patients with immune infiltration. Radiomics features were screened using LASSO analysis. Eight ML algorithms were selected for diagnostic analysis of the test set. Receiver operating characteristic (ROC) curve was used to evaluate the performance of the model. Draw decision curve analysis (DCA) to evaluate the clinical personalized medical value of the predictive model. The high/low subtypes of immune infiltration levels obtained by optimisation based on the Boruta algorithm were statistically different in the survival analysis of ccRCC patients. Multifactorial immune infiltration level combined with clinical factors better predicted survival of ccRCC patients, and ccRCC with high immune infiltration may benefit more from anti-PD-1 therapy. Among the eight machine learning models, ExtraTrees had the highest test and training set ROC AUCs of 1.000 and 0.753; in the test set, LR and LightGBM had the highest sensitivity of 0.615; LR, SVM, ExtraTrees, LightGBM and MLP had higher specificities of 0.789, 1.000, 0.842, 0.789 and 0.789, respectively; and LR, ExtraTrees and LightGBM had the highest accuracy of 0. 719, 0.688 and 0.719 respectively. Therefore, the CT-based ML achieved good predictive results in predicting immune infiltration in ccRCC, with the ExtraTrees machine learning algorithm being optimal. The use of radiomics model based on renal CT images can be noninvasively used to predict the immune infiltration level of ccRCC as well as combined with clinical information to create columnar plots predicting total survival in people with ccRCC and to predict responsiveness to ICI therapy, findings that may be useful in stratifying the prognosis of patients with ccRCC and guiding clinical practitioners to develop individualized regimens in the treatment of their patients.